Evidence map›Paper›PMID 38251468›Full record

ArticleEBioMedicine2023

Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?

Laura Ziegler, Verena Klemis, Tina Schmidt, Sophie Schneitler, Christina Baum, Jürgen Neumann, Sören L Becker, Barbara C Gärtner, Urban Sester, Martina Sester

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Laura ZieglerDepartment of Transplant and Infection Immunology, Saarland University, Germany.
Verena KlemisDepartment of Transplant and Infection Immunology, Saarland University, Germany.
Tina SchmidtDepartment of Transplant and Infection Immunology, Saarland University, Germany.
Sophie SchneitlerDepartment of Medical Microbiology and Hygiene, Saarland University, Germany.
Christina BaumOccupational Health Care Center, Saarland University, 66421, Homburg, Germany.
Jürgen NeumannDepartment of Occupational Health, Robert Bosch GmbH, 66424, Homburg, Germany.
Sören L BeckerDepartment of Medical Microbiology and Hygiene, Saarland University, Germany.
Barbara C GärtnerDepartment of Medical Microbiology and Hygiene, Saarland University, Germany.
Urban SesterDepartment of Nephrology, SHG-Klinikum Völklingen, 66333, Völklingen, Germany.
Martina SesterDepartment of Transplant and Infection Immunology, Saarland University, Germany. Electronic address: martina.sester@uks.eu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesHumansImmunization, SecondaryCOVID-19 Vaccines

Identifiers

PMID38251468
PMCPMC10628342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.